Durable Complete Response to Pembrolizumab in MSI-H Advanced Pancreatic Cancer

Authors

İrfan Alişan (ORCID: https://orcid.org/0000-0002-9473-9476)
Mehmet Türker (ORCID: https://orcid.org/0000-0003-4163-917X)
Mahmut Büyükşimşek (ORCID: https://orcid.org/0000-0001-6356-9059)
Ali Türker (ORCID: https://orcid.org/0000-0001-8127-2961)
İbrahim Türker (ORCID: https://orcid.org/0000-0003-0871-5636)

Publication Details

Journal: Clinical Laboratory
Published: 2025-01-01
DOI: https://doi.org/10.7754/clin.lab.2025.250144
Primary Topic: Pancreatic and Hepatic Oncology Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Durable Complete Response to Pembrolizumab in MSI-H Advanced Pancreatic Cancer

İrfan Alişan, Mehmet Türker, Mahmut Büyükşimşek, Ali Türker et al.

Jan 1, 2025

Clinical Laboratory

Pancreatic and Hepatic Oncology Research

article

Durable Complete Response to Pembrolizumab in MSI-H Advanced Pancreatic Cancer

İrfan Alişan, Mehmet Türker, Mahmut Büyükşimşek, Ali Türker, İbrahim Türker

January 1, 2025article en

Abstract

No abstract available for this paper.

Clinical LaboratoryVol. 71(08/2025)

Good health and well-being

Openalex Percentile: Top 71%

Pancreatic and Hepatic Oncology Research

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Durable Complete Response to Pembrolizumab in MSI-H Advanced Pancreatic Cancer — İrfan Alişan, Mehmet Türker, et al. · Clinical Laboratory (2025) | TGRS Research Map | TGRS